atherosclerotic cardiovascular disease (ASCVD)
Conditions
Interventions
control group:Dietary guidance and exercise guidance
interventional group:Qingzhikang (2 capsules each time, 3 times a day) and coenzyme Q10 capsule (1 capsule each time, 3 times a day)
Sponsors
Department of Nutrition, the First Medical Center of Chinese People's Liberation Army General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Nation: any nation; 2. Gender: men and women; 3. Age: greater than or equal to 18 years old, less than 65; 4. Long-term medication; 5. Willing to join the test.
Exclusion criteria
Exclusion criteria: 1. Previously suffering from atherosclerotic cardiovascular diseases, such as acute coronary syndrome, history of myocardial infarction, stable or unstable angina pectoris, coronary artery or other vascular reconstruction, atherosclerotic stroke or TIA, and atherosclerotic peripheral artery disease; 2. Patients with cerebrovascular accident, severe trauma or major surgery; 3. Dyslipidemia caused by diabetic nephropathy syndrome, hypothyroidism, gout, acute or chronic hepatobiliary diseases; 4. Patients with severe primary diseases such as liver, kidney and hematopoietic systems and mental disorders; 5. Pregnancy or lactation women; 6. Allergic constitutions and persons allergic to test drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood-lipid; | — |
Secondary
| Measure | Time frame |
|---|---|
| inflammatory factors;IMT detection of carotid artery ultrasonography;plaque score;10-year risk assessment of cardiovascular disease and atherosclerosis index (AI); | — |
Countries
China
Contacts
Public ContactLiu Yinghua
Department of Nutrition, the First Medical Center of Chinese People's Liberation Army General Hospital
Outcome results
None listed